Neurocrine Biosciences Inc (NAS:NBIX)
$ 126.59 -1.32 (-1.03%) Market Cap: 12.82 Bil Enterprise Value: 11.84 Bil PE Ratio: 33.94 PB Ratio: 4.71 GF Score: 85/100

Neurocrine Biosciences Inc at Evercore ISI HealthCONx Conference Transcript

Dec 01, 2020 / 06:50PM GMT
Release Date Price: $94.83 (-0.12%)
Joshua Elliott Schimmer
Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst

All right. Welcome, everyone. It's Josh Schimmer from Evercore ISI biotech team. Pleased to introduce the management of Neurocrine Biosciences. We have Kevin Gorman, President and Chief Executive Officer; Matt Abernethy, Chief Financial Officer; and Eiry Roberts, Chief Medical Officer.

Questions & Answers

Joshua Elliott Schimmer
Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst

So thank you so much for joining. Suitably remote, as I think Neurocrine's been learning all about remote access, particularly in the world of psychiatry in the pandemic. So maybe tell us -- talk to us a little bit about psychiatry life in a pandemic and what that means for INGREZZA.

Kevin C. Gorman
Neurocrine Biosciences, Inc. - CEO & Director

Yes. Good to see you, Josh, and I want to thank you very much for the opportunity to speak here at Evercore's meeting. Also, we will be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot